Inso Biosciences

company

About

Inso Bio is a Cornell University-based early-stage biotech company that develops platform technology for biological sample processing.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$250K
Industries
Biotechnology,Genetics,Life Science
Founded date
Jun 15, 2018
Number Of Employee
1 - 10
Operating Status
Active

Inso Bio is a biotech spinout company from Cornell University that develops laboratory tools for biological sample processing.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$500K
Inso Biosciences has raised a total of $500K in funding over 2 rounds. Their latest funding was raised on Jun 15, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 15, 2021 Grant $250K 1 Detail
May 15, 2020 Grant $25K 1 Detail
Jan 1, 2020 Grant $225K 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Inso Biosciences is funded by 2 investors. National Institutes of Health and National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Grant
National Science Foundation Grant